{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:52:42Z","timestamp":1774659162433,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-82821-w","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T08:28:23Z","timestamp":1735374503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prostate-specific antigen testing in the United States during 2008\u20132022 in relation to the US preventive services task force recommendations"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4201-0704","authenticated-orcid":false,"given":"Ray M.","family":"Merrill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8598-8797","authenticated-orcid":false,"given":"Ian S.","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"82821_CR1","doi-asserted-by":"crossref","unstructured":"Moyer, V. A. & U.S. Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force (USPSTF) recommendation statement. Ann. Intern. Med. 157(2):120\u2013134. (2012).","DOI":"10.7326\/0003-4819-157-2-201207170-00459"},{"key":"82821_CR2","doi-asserted-by":"publisher","unstructured":"US Preventive Services Task Force et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 319(18):1901\u20131913. (2018). https:\/\/doi.org\/10.1001\/jama.2018.3710. Erratum in: JAMA. 319(23):2443 (2018).","DOI":"10.1001\/jama.2018.3710"},{"key":"82821_CR3","unstructured":"American Cancer Society. Cancer Facts for Men. https:\/\/www.cancer.org\/cancer\/risk-prevention\/understanding-cancer-risk\/cancer-facts\/cancer-facts-for-men.html#:~:text=Age%2050%20for%20men%20at,prostate%20cancer%20before%20age%2065. Accessed April 3. (2024)."},{"key":"82821_CR4","doi-asserted-by":"publisher","first-page":"8646314","DOI":"10.1155\/2022\/8646314","volume":"2022","author":"RM Merrill","year":"2022","unstructured":"Merrill, R. M., Otto, S. A. & Hammond, E. B. Prostate-specific antigen screening according to health professional counseling and age in the United States. Prostate Cancer 2022, 8646314. https:\/\/doi.org\/10.1155\/2022\/8646314 (2022).","journal-title":"Prostate Cancer"},{"issue":"6","key":"82821_CR5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/jnci\/djaa171","volume":"113","author":"KH Kensler","year":"2021","unstructured":"Kensler, K. H. et al. Racial and ethnic variation in PSA testing and prostate cancer incidence following the 2012 USPSTF recommendation. J. Natl. Cancer Inst. 113(6), 719\u2013726. https:\/\/doi.org\/10.1093\/jnci\/djaa171 (2021).","journal-title":"J. Natl. Cancer Inst."},{"key":"82821_CR6","unstructured":"Healthy People Behavioral Risk Factor Surveillance System (BRFSS). (2030). https:\/\/health.gov\/healthypeople\/objectives-and-data\/data-sources-and-methods\/data-sources\/behavioral-risk-factor-surveillance-system-brfss. Accessed April 3, 2024."},{"key":"82821_CR7","unstructured":"Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2008 summary data quality report. (2011). https:\/\/www.cdc.gov\/brfss\/annual_data\/2008\/pdf\/2008_summary_data_quality_report.pd. Published February 11, Accessed April 3, 2024."},{"key":"82821_CR8","unstructured":"Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2010 summary data quality report. Published May, 2 (2011). https:\/\/www.cdc.gov\/brfss\/annual_data\/2018\/pdf\/2018-sdqr-508.pdf. Accessed April 3, 2024."},{"key":"82821_CR9","unstructured":"Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2012 summary data quality report. (2013). https:\/\/www.cdc.gov\/brfss\/annual_data\/2012\/pdf\/summarydataqualityreport2012_20130712.pdf. Published July 3, Accessed April 3, 2024."},{"key":"82821_CR10","unstructured":"Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2014 summary data quality report. (2015). https:\/\/www.cdc.gov\/brfss\/annual_data\/2014\/pdf\/2014_dqr.pdf. Published July 29, Accessed April 3, 2024."},{"key":"82821_CR11","unstructured":"Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2016 summary data quality report. (2017). https:\/\/www.cdc.gov\/brfss\/annual_data\/2016\/pdf\/2016-sdqr.pdf. Published June 29, Accessed April 3, 2024."},{"key":"82821_CR12","unstructured":"Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2018 summary data quality report. (2019). https:\/\/www.cdc.gov\/brfss\/annual_data\/2018\/pdf\/2018-sdqr-508.pdf. Published July 17, Accessed April 3, 2024."},{"key":"82821_CR13","unstructured":"Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2020 summary data quality report. (2019). https:\/\/www.cdc.gov\/brfss\/annual_data\/2020\/pdf\/2020-sdqr-508.pdf. Published August 2, Accessed April 3, 2024."},{"key":"82821_CR14","unstructured":"Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. 2022 summary data quality report. (2023). https:\/\/www.cdc.gov\/brfss\/annual_data\/2022\/pdf\/2022-dqr-508.pdf. Published August 8, Accessed April 3, 2024."},{"key":"82821_CR15","unstructured":"Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System. (2024). https:\/\/www.cdc.gov\/brfss\/. Accessed April 3."},{"key":"82821_CR16","unstructured":"Surveillance, E. & Results, E. (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Data, 8 Registries, Nov 2022 Sub (1975\u20132020) - Linked To County Attributes - Time Dependent (1990\u20132021) Income\/Rurality, 1969\u20132021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission."},{"issue":"4","key":"82821_CR17","doi-asserted-by":"publisher","first-page":"e237504","DOI":"10.1001\/jamanetworkopen.2023.7504","volume":"6","author":"S Kalavacherla","year":"2023","unstructured":"Kalavacherla, S. et al. Low-value prostate-specific antigen screening in older males. JAMA Netw. Open 6(4), e237504. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.7504 (2023).","journal-title":"JAMA Netw. Open."},{"issue":"3","key":"82821_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s10552-023-01821-9","volume":"35","author":"S Khan","year":"2024","unstructured":"Khan, S. et al. The impact of marital status on tumor aggressiveness, treatment, and screening among black and white men diagnosed with prostate cancer. Cancer Causes Control. 35(3), 531\u2013539. https:\/\/doi.org\/10.1007\/s10552-023-01821-9 (2024).","journal-title":"Cancer Causes Control"},{"issue":"2","key":"82821_CR19","first-page":"6702","volume":"20","author":"MD Tyson","year":"2013","unstructured":"Tyson, M. D. et al. Marital status and prostate cancer outcomes. Can. J. Urol. 20(2), 6702\u20136706 (2013).","journal-title":"Can. J. Urol."},{"issue":"9","key":"82821_CR20","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s10654-021-00781-1","volume":"36","author":"C Salmon","year":"2021","unstructured":"Salmon, C. et al. Marital status and prostate cancer incidence: a pooled analysis of 12 case-control studies from the PRACTICAL consortium. Eur. J. Epidemiol. 36(9), 913\u2013925. https:\/\/doi.org\/10.1007\/s10654-021-00781-1 (2021).","journal-title":"Eur. J. Epidemiol."},{"issue":"10","key":"82821_CR21","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaoncol.2022.2970","volume":"8","author":"MV Sherer","year":"2022","unstructured":"Sherer, M. V., Qiao, E. M., Kotha, N. V., Qian, A. S. & Rose, B. S. Association between prostate-specific antigen screening and prostate cancer mortality among non-hispanic black and non-hispanic white US veterans. JAMA Oncol. 8(10), 1471\u20131476. https:\/\/doi.org\/10.1001\/jamaoncol.2022.2970 (2022).","journal-title":"JAMA Oncol."},{"issue":"8","key":"82821_CR22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10552-019-01194-y","volume":"30","author":"S Khan","year":"2019","unstructured":"Khan, S. et al. The association of marital status and mortality among men with early-stage prostate cancer treated with radical prostatectomy: insight into post-prostatectomy survival strategies. Cancer Causes Control. 30(8), 871\u2013876. https:\/\/doi.org\/10.1007\/s10552-019-01194-y (2019).","journal-title":"Cancer Causes Control"},{"issue":"4","key":"82821_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/pcan.2017.32","volume":"20","author":"KA Moses","year":"2017","unstructured":"Moses, K. A. et al. The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study. Prostate Cancer Prostatic Dis. 20(4), 424\u2013429. https:\/\/doi.org\/10.1038\/pcan.2017.32 (2017).","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"10","key":"82821_CR24","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1158\/1055-9965","volume":"19","author":"SA Fedewa","year":"2010","unstructured":"Fedewa, S. A., Etzioni, R., Flanders, W. D., Jemal, A. & Ward, E. M. Association of insurance and race\/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004\u20132006. Cancer Epidemiol. Biomarkers Prev. 19(10), 2437\u20132444. https:\/\/doi.org\/10.1158\/1055-9965 (2010).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"1","key":"82821_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12894-022-01045-0","volume":"22","author":"IE Kim Jr","year":"2022","unstructured":"Kim, I. E. Jr et al. Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations. BMC Urol. 22(1), 91. https:\/\/doi.org\/10.1186\/s12894-022-01045-0 (2022).","journal-title":"BMC Urol."},{"issue":"3","key":"82821_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ajur.2017.06.004","volume":"4","author":"KB Lim","year":"2017","unstructured":"Lim, K. B. Epidemiology of clinical benign prostatic hyperplasia. Asian J. Urol. 4(3), 148\u2013151. https:\/\/doi.org\/10.1016\/j.ajur.2017.06.004 (2017).","journal-title":"Asian J. Urol."},{"key":"82821_CR27","unstructured":"American Cancer Society. Prostate Cancer Risk Factors. (2024). https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/causes-risks-prevention\/risk-factors.html#:~:text=Prostate%20cancer%20is%20rare%20in,in%20men%20older%20than%2065. Accessed April 3."},{"issue":"2","key":"82821_CR28","first-page":"000164","volume":"4","author":"J Wiedemer","year":"2021","unstructured":"Wiedemer, J., McKoy, T. & Yu, M. Benign prostatic hyperplasia in African American men merits greater consideration in academic medicine. Ann. Adv. Biomed. Sci. 4(2), 000164 (2021).","journal-title":"Ann. Adv. Biomed. Sci."},{"issue":"2","key":"82821_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/00001648-199703000-00001","volume":"8","author":"RM Merrill","year":"1997","unstructured":"Merrill, R. M. & Brawley, O. W. Prostate cancer incidence and mortality rates among white and black men. Epidemiology 8(2), 126\u2013131. https:\/\/doi.org\/10.1097\/00001648-199703000-00001 (1997).","journal-title":"Epidemiology"},{"key":"82821_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1471-2288-13-49","volume":"13","author":"C Pierannunzi","year":"2013","unstructured":"Pierannunzi, C., Hu, S. S. & Balluz, L. A systematic review of publications assessing reliability and validity of the behavioral risk factor Surveillance System (BRFSS), 2004\u20132011. BMC Med. Res. Methodol. 13, 49. https:\/\/doi.org\/10.1186\/1471-2288-13-49 (2013).","journal-title":"BMC Med. Res. Methodol."},{"key":"82821_CR31","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1200\/CCI.21.00074","volume":"5","author":"HW Kaufman","year":"2021","unstructured":"Kaufman, H. W., Chen, Z., Niles, J. K., Radcliff, J. & Fesko, Y. Patterns of prostate-specific antigen testing and prostate biopsies during the COVID-19 pandemic. JCO Clin. Cancer Inf. 5, 1028\u20131033. https:\/\/doi.org\/10.1200\/CCI.21.00074 (2021).","journal-title":"JCO Clin. Cancer Inf."},{"key":"82821_CR32","doi-asserted-by":"publisher","unstructured":"Chen, R. C., Haynes, K., Du, S., Barron, J. & Katz, A. J. Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncol. 1;7(6):878\u2013884. https:\/\/doi.org\/10.1001\/jamaoncol.2021.0884 (2021).","DOI":"10.1001\/jamaoncol.2021.0884"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82821-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82821-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82821-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T21:29:55Z","timestamp":1735421395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82821-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["82821"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-82821-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31345"}}